Lapatinib alleviates TOCP-induced axonal damage in the spinal cord of mouse. (15th May 2021)

• Record Type: Journal Article
• Authors: Xu, Hai-Yang; Sun, Ying-Jian; Sun, Yan-Yan; Wu, Yi-Jun; Xu, Ming-Yuan; Chen, Li-Ping; Zhu, Li
• Is Part Of: Neuropharmacology. Volume 189(2021)
• Publication Date: 2021-05-15
• Subjects: Lapatinib -- Mouse -- Neuregulin-1 -- Sciatic nerve -- Spinal cord -- Tri-o-cresyl phosphate; Neuropsychopharmacology -- Periodicals; Autonomic Agents -- Periodicals; Neuropsychopharmacologie -- Périodiques; Neuropsychopharmacology; Periodicals; Electronic journals; 615.78
• DOI: 10.1016/j.neuropharm.2021.108535
• Languages: English
• ISSNs: 0028-3908

Abstract

Abstract: Neuregulin-1 (NRG1), a family of EGF-like factors that activates ErbB receptors, can regulate the proliferation, migration, and myelinating of Schwann cells. We previously reported that NRG1/ErbB signal is responsible for organophosphate (OP)-induced delayed neuropathy (OPIDN) in hens, a susceptive animal model to neuropathic organophosphorous compounds. Our previous study discovered that a neuropathic OP, tri- o -cresyl phosphate (TOCP) activated NRG1/ErbB signaling pathway in both spinal cord and sciatic nerves of hens during the formation of OPIDN and lapatinib, a non-selective antagonist of ErbB1 and ErbB2 receptors, alleviated the toxicity. In this study, we intended to further look into the potential role of NRG1 in the pathogenesis of TOCP-induced axon damage in spinal cord and sciatic nerves and whether lapatinib could also rescue this damage in mice, an OPIDN-resistant animal model. The results revealed that no obvious toxic signs were observed after single TOCP exposure. However, slight histopathological wreck in lumbar spinal cord and sciatic nerves was found following TOCP intoxication, and the damage in sciatic nerves was characterized by axon degeneration of myelin sheath but not the loss of neural skeleton. Only histopathological damage induced by TOCP in spinal cord could be prevented by lapatinib. The translational expression of NRG1/ErbB signaling molecules was analyzed by both in vivo and in vitro studies. In general, NRG1/ErbB pathway was activated by TOCP while combined treatment with lapatinib attenuated TOCP-induced NRG1/ErbB signaling cascade. The results implied that NRG1/ErbB system may predominately play functional role in spinal cord (central nervous system) but not in sciatic nerves (peripheral nervous system) of mouse subjected to neurotoxic OP, which was confirmed by the study in vitro that lapatinib was not able to attenuate TOCP-induced neurotoxicity in rodent Schwann cell line RSC 96 cells. Highlights: TOCP induces axonal cytoskeletal degradation in spinal cord but not sciatic nerves. TOCP activates NRG1/ErbB neural signaling pathway in vivo and in vitro . Lapatinib could alleviate TOCP-induced axonal damage by abating the NRG1 activity.